An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Trulance

Chemical Nameplecanatide
Dosage FormTablet (oral; 3 mg)
Drug ClassReceptor agonists
SystemDigestive
CompanySalix Pharmaceuticals
Approval Year2017

Indication

  • To treat chronic idiopathic constipation and irritable bowel syndrome with constipation in adults.
Last updated on 10/20/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Trulance (Plecanatide) Prescribing Information2017Salix Pharmaceuticals, Bridgewater, NJ
Document TitleYearSource
Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis. 2019The Lancet. Gastroenterology & Hepatology
Efficacy of secretagogues in patients with irritable bowel syndrome with constipation: Systematic review and network meta-analysis. 2018Gastroenterology
Efficacy and tolerability of guanylate cyclase-C agonists for irritable bowel syndrome with constipation and chronic idiopathic constipation: A systematic review and meta-analysis. 2018The American Journal of Gastroenterology